The Korean Journal of Internal Medicine

Search

Close

Original Article
Korean J Med. 2005;69(3):906-909.
증례 : Simvastatin 복용 중인 환자에서 Clopidogrel 병합요법 후 발생한 횡문근 융해증 1예
권용수&#;김승태&#;송필상&#;류동열&#;최소연&#;이진영&#;김덕경, , , , , ,
A case of rabdomyolysis associated with simvastatin‐clopidogrel combination therapy
Yong Soo Kwon, Seung Tai Kim, Pil Sang Song, Dong Ryeol Ryu, So Yeon Choi, Jin Young Lee, Duk-Kyung Kim
Department of Internal Medicine, Chungbuk National University College of Medicine, Cheongju, Korea


Abstract
Simvastatin, the 3‐hydroxy‐3methylglutaryl coenzyme (HMG‐CoA) reductase inhibitor is effective in reduction the risk of coronary event and are generally well tolerated. Rhabdomyolysis is uncommon complication of this drug. We describe a case of rhabdomyolysis associated with concomitant use of simvastatin and clopidogrel. Rhabdomyolysis occurred 30 days after clopidogrel added to a chronic stable dose of simvastatin, and resolved after discontinuation of simvastatin and clopidogrel. We recommend careful monitoring when clopidogrel is given to patients receiving simvastatin.(Korean J Med 69:S906-S909, 2005)

Keywords :Rhabdomyolysis, Clopidogrel, Simvastatin.
hanmi ckdpharm. AMGEN
Memo patch yungjin daewoongbio

Go to Top